Overall rank by patents
#558
Across all tracked assignees
USPTO PatentsView assignee record - 803 granted patents across 164 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
KING holds 803 US patents across 164 technology areas, rank #558 of 50,000 tracked assignees.
KING Faisal University has been granted 803 US utility patents between 2017 and 2025, placing KING Faisal University at rank #558 across all assignees tracked by PlainPatent. This portfolio spans 164 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.8 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, KING Faisal University is one of the broader-portfolio assignees in the PatentsView dataset. By volume, KING sits between C.r. Bard, Inc. (808 patents, rank #554) and Hefei BOE Optoelectronics Technology Co., Ltd. (802 patents, rank #562) - the closest US assignees by grant volume. The composite Innovation Score of 74.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 801 grants, compared with 2 in the 2015–2019 window, a +39950% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. KING Faisal University's 10.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark KING Faisal University against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
C.R. Bard, Inc.
808 patents
Mitsubishi Gas Chemical Company, Inc.
808 patents
Meta Platforms, Inc.
807 patents
Baker Hughes Oilfield Operations LLC
803 patents
MANDOM CORPORATION
803 patents
Rohm and Haas Company
803 patents
UT-BATTELLE, LLC
803 patents
KING FAISAL UNIVERSITY
803 patents
HEFEI BOE OPTOELECTRONICS TECHNOLOGY CO., LTD.
802 patents
What this shows KING holds 803 patents at rank #558, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #558 in granted patent volume.
Other assignees with the most granted patents in KING's primary technology class.
KING's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
75 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 0.1% |
| 2019 | 1 | 0.1% |
| 2020 | 3 | 0.4% |
| 2021 | 2 | 0.2% |
| 2022 | 10 | 1.2% |
| 2023 | 107 | 13.3% |
| 2024 | 630 | 78.5% |
| 2025 | 49 | 6.1% |
Top 15 of 164 technology areas
Overall rank by patents
#558
Across all tracked assignees
74.6 out of 100
How to use this portfolio
KING's 803 grants land it in the top 0.1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.